Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 12:55 AM
Ignite Modification Date:
2025-12-25 @ 12:55 AM
NCT ID:
NCT05515367
Brief Summary:
A Phase 4, 52 week, single arm, multicentre post marketing surveillance to evaluate the safety of Desidustat for the treatment of anemia in subjects with chronic kidney disease (CKD)
Detailed Description:
The study is being planned to evaluate long term safety of Desidustat with CKD patient.
Total 1004 population i.e 502 dialysis dependent, 502 dialysis independent.
Study:
NCT05515367
Study Brief:
Protocol Section:
NCT05515367